DaVita Inc. is an American healthcare company. It is best known as one of the largest kidney care providers in the United States.

Hospital

DaVita

Robert Lang has been in the financial industry for over 20 years. Robert started their career at ING, where they were the Chief Distribution Officer for Insurance Europe. Robert then moved to [HSBC](/org/hsbc), where they were the Managing Director for [HSBC](/org/hsbc) Insurance Hong Kong. In 2011, they joined UBS Wealth Management Europe as the Chief of Staff and Head of Strategy & Transformation. In February 2013, they became the Managing Director for International Markets at [Bupa](/org/bupa). Robert is currently the President & CEO of DaVita International.

Robert Lang has a Master of Business Administration (MBA) from the [London Business School](/org/london-business-school) and a Bachelor of Economics / Bachelor of Arts (Honours) from [Monash University](/org/monash-university).

Robert Lang reports to Javier J. Rodriguez, CEO. They are on a team with Kathleen A. Waters - Chief Legal Officer, Kenny Gardner - Chief People Officer, and Jeffrey Giullian - Chief Medical Officer, DaVita Kidney Care.

Robert Lang

Adam H. Schechter has been one of the directors since September 2022. Mr. Schechter has served as Chairman of the Board of Laboratory Corporation of America Holdings, a clinical laboratory company (“LabCorp”), since May 2020, a director since April 2013, and as President and Chief Executive Officer of LabCorp since November 2019. Mr. Schechter previously served as special advisor to the Chief Executive Officer of Merck & Co., Inc., a multinational pharmaceutical company (“Merck”), from January 2019 to July 2019. Prior to that, Mr. Schechter was an Executive Vice President of Merck, where he was a member of Merck’s executive committee, pharmaceutical and vaccines operating committee, and President of Merck’s Global Human Health Division, which includes Merck’s worldwide pharmaceutical and vaccine businesses, from 2010 to 2018. Prior to becoming President, of Global Human Health, Mr. Schechter served as President, Global Pharmaceutical Business of Merck from 2007 to 2010. He currently serves as a Board Member for Water.org and an executive board member for the National Alliance for Hispanic Health. In 2022, Mr. Schechter earned the CERT Certificate in Cybersecurity Oversight.

Adam H. Schechter

Joel Ackerman became our chief financial officer on February 27, 2017 after serving as our senior vice president, finance from February 21, 2017 to February 26, 2017. Prior to joining us, Mr. Ackerman was the chief executive officer and a member of the board of directors of [Champions Oncology](/org/champions-oncology), Inc., a company engaged in the development of advanced technology solutions and services to personalize the development and use of oncology drugs, since October 2010. Mr. Ackerman is currently the Chairman of [Champions Oncology](/org/champions-oncology). Mr. Ackerman served as a managing director at [Warburg Pincus](/org/warburg-pincus), a global private equity firm, where he led the healthcare services team for 10 years from January 1999 to September 2008. He sits on the board of directors at Kindred Healthcare, Inc., a position he has held since December 2008, and previously served on the board of directors of Coventry Health Care, Inc. a national managed care company, from September 1999 until its acquisition by Aetna Inc. in May 2013. He is also chairman of the board of [One Acre Fund](/org/one-acre-fund), a not-for-profit organization that focuses on smallholder agriculture, and serves more than 700,000 subsistence farmers in Africa.

Joel Ackerman

Javier Rodriguez is the chief executive officer of [DaVita](/org/davita) Inc. (NYSE: DVA), a FORTUNE 500 company providing health care services to kidney disease patients throughout the United States and internationally. [DaVita](/org/davita) strives to improve patients’ quality of life through clinical innovation and integrated, personalized care. [DaVita](/org/davita)’s global operations include 65,000 teammates serving 225,000 patients treating in-center, in their homes and in hospitals.

Mr. Rodriguez has spent more than 20 years driving [DaVita](/org/davita)’s transformation for how kidney care is delivered. He is passionate about creating an integrated, high-quality experience for all patients with kidney disease, while lowering costs for the health care system.

Mr. Rodriguez earned a master’s degree from [Harvard Business School](/org/harvard-business-school) and completed an executive program at Stanford Graduate School of Business. He earned a bachelor’s degree in finance and marketing from [Boston College](/org/boston-college). Mr. Rodriguez was named one of the 2015 Top 10 Leaders by Hispanic Executive magazine. He also serves on the board of directors for the [Denver Metro Chamber of Commerce](/org/denver-metro-chamber-of-commerce).

Javier J. Rodriguez

Mr. Hollar offers more than 25 years of financial experience spanning the health care, transportation, manufacturing and retail sectors to the board. Mr. Hollar currently serves as chief financial officer of [Cardinal Health](/org/cardinal-health), Inc., a globally integrated health care services and products company with over $160 billion in 2021 revenues. Mr. Hollar leads financial activities across the [Cardinal Health](/org/cardinal-health) enterprise, including financial strategy, capital deployment, treasury, tax, investor relations, accounting and reporting.

Before joining [Cardinal Health](/org/cardinal-health), Inc. in 2020, Mr. Hollar served as chief financial officer for Tenneco Inc., a global automotive products and services company, and as chief financial officer for the Sears Holdings Corporation. Prior to that, he served in senior leadership positions at Delphi, Inc. and Navistar International Corporation.

Mr. Hollar earned his Master of Business Administration from the University of Chicago and his Bachelor of Science degree in business from [Indiana University](/org/indiana-university).

Jason M. Hollar

As the Chief People Officer, Kenny oversees the entire human resources function, taking care of ~65,000 teammates across the world. He has been with [DaVita](/org/davita) for nearly a decade and most recently served the company as a group vice president (GVP), overseeing field operations in the Southeast as well as [DaVita](/org/davita)’s diagnostic laboratory.

Prior to joining [DaVita](/org/davita), Mr. Gardner previously worked as an investment banker at [Morgan Stanley](/org/morgan-stanley) focused on Mergers and Acquisitions.

Mr. Gardner holds a Bachelor of Science degree from the Florida A&M University along with an MBA from the Stanford Graduate School of Business where he was recognized as an Arbuckle Leadership Fellow.

Kenny is committed to the broader South Florida community and is actively engaged with the 5000 Role Models of Excellence Project, Food for the Poor, Perez Art Museum, Frost Museum of Science and Golden Cane Society.

Kenny Gardner

Charles G. Berg has been one of our directors since March 2007, and from November 2016 until December 2017, also served as executive chair of our former integrated healthcare business, DaVita Medical Group (“DMG”). On March 25, 2019, Mr. Berg joined the board of directors of Turn-Key Health, an Enclara Healthcare Company, serving health plans, provider organizations and their members who experience a serious or advanced illness. From 2008 to 2013, Mr. Berg served as executive chairman of WellCare Health Plans, Inc. (“WellCare”), a provider of managed care services for government-sponsored health care programs. Mr. Berg served as non-executive chairman of the board of directors of WellCare from January 2011 until his retirement in May 2013. From January 2007 to April 2009, Mr. Berg was a senior advisor to Welsh, Carson, Anderson & Stowe, a private equity firm. From April 1998 to July 2004, Mr. Berg held various executive positions, including executive vice president-medical delivery, president and chief operating officer with Oxford Health Plans, Inc. (“Oxford”), a health benefit plan provider. He was the chief executive officer when Oxford was acquired by [UnitedHealth Group](/org/unitedhealth-group). He then became an executive of [UnitedHealth Group](/org/unitedhealth-group) and was primarily responsible for integrating the Oxford business. Mr. Berg currently serves as a member of the Operating Council & Senior Advisory Board of Consonance Capital Partners, a private equity firm, and the board of directors of Justworks, Inc., a private human resources and payment company.

Charles G. Berg

Pamela M. Arway has been one of our directors since May 2009. From 2005 to 2008, Ms. Arway served as the president of the Japan, Asia-Pacific, Australia region for American Express International, Inc., a global payment services and travel company. Ms. Arway joined the American Express Company in 1987, and subsequently served in various capacities, including as chief executive officer of American Express Australia Limited from 2004 to 2005 and as executive vice president of Corporate Travel, North America from 2000 to 2004. Prior to her retirement in October 2008, she also served as advisor to the American Express Company’s chairman and chief executive officer. Since May 2010, Ms. Arway has been a member of the board of [The Hershey Company](/org/the-hershey-company), a chocolate and confectionery company. She currently serves as a member of the Compensation and Finance and Risk Management Committees of [The Hershey Company](/org/the-hershey-company)’s board. Since March 2014, Ms. Arway has been a member of the board of Iron Mountain Incorporated, an enterprise information management services company and currently serves as chair of its Compensation Committee and as a member of the Nominating and Governance Committee.

Pamela M. Arway

Phyllis R. Yale has been one of our directors since July 2016. Ms. Yale has been an Advisory Partner with Bain & Company, Inc. (“Bain”), a global management consulting firm, since July 2010. Ms. Yale was a partner with Bain from 1987 to July 2010, and was a leader in building Bain’s healthcare practice. In her role at Bain, Ms. Yale works with healthcare payors, providers, and medical device companies, and frequently advises the world’s leading private equity firms on their investments in the healthcare sector. She has served as a member of the board of directors of several public and private companies in the healthcare sector, and currently serves as Chair of the board of directors of Blue Cross Blue Shield of Massachusetts, a not-for-profit health plan headquartered in Boston. Ms. Yale previously served as Chair of the board of directors of Kindred HealthCare, Inc., a provider of long-term healthcare services in the United States, from January 2010 until July 2018, a director of National Surgical Hospitals, a privately held specialty hospital operator, and a director of ValueOptions, Inc., a health improvement company specializing in mental and emotional wellbeing and recovery, which merged with [Beacon Health Strategies](/org/beacon-health-strategies) during 2014.

Phyllis R. Yale

Dr. Naljayan joined DaVita in 2016 and most recently served as vice president of clinical affairs within DaVita's home dialysis program. In that role, he created and led DaVita's home physician support network—a program that helps empower nephrologists to advocate for home dialysis with eligible patients. Since Dr. Naljayan joined DaVita, there has been a 35% increase in home hemodialysis and peritoneal dialysis treatments.

Mihran Naljayan

John Winstel

Paul J. Diaz has been one of our directors since July 2007. Mr. Diaz currently serves as a general partner of Cressey & Company, a private equity firm focused exclusively on investing in and building healthcare businesses, a position he has held since September 2017. Mr. Diaz was an operating partner at Cressey & Company from March 2016 to September 2017. Since August 2014, Mr. Diaz has served as a partner at Guidon Partners LP, a private investment partnership. He served as executive vice chairman of Kindred Healthcare, Inc. (“Kindred”), a provider of long-term healthcare services in the United States, from March 2015 to March 2016, chief executive officer from January 2004 to March 2015, as well as president from January 2002 to May 2012 and as chief operating officer from January 2002 to December 2003. Prior to joining Kindred, Mr. Diaz was the managing member of Falcon Capital Partners, LLC, a private investment and consulting firm, and from 1996 to July 1998, Mr. Diaz served in various executive capacities with Mariner Health Group, Inc., a healthcare facility operator, including as executive vice president and chief operating officer. Mr. Diaz serves on the board of [Performance Health](/org/performance-health-llc), a private medical supply distribution company, the board of trustees of [Johns Hopkins Medicine](/org/johns-hopkins-medicine) and the board of visitors of the Georgetown University Law Center. Mr. Diaz also previously served on the board of PharMerica Corporation, and from May 2002 until July 2018, served on the board of Kindred.

Paul J. Diaz

John M. Nehra has been one of our directors since November 2000. From 1989 until his retirement in August 2014, Mr. Nehra was affiliated with [New Enterprise Associates](/org/new-enterprise-associates) (‘‘NEA’’), a venture capital firm, including, from 1993 until his retirement, as general partner of several of its affiliated venture capital limited partnerships. Mr. Nehra also served as managing general partner of Catalyst Ventures, a venture capital firm, from 1989 to 2013. Mr. Nehra served on the boards of a number of NEA’s portfolio companies until his retirement in August 2014 and remains a retired special partner of NEA.

John M. Nehra

Michael D. Staffieri

Kathleen A. Waters

James O. Hearty

Jeffrey Giullian, MD, serves as chief medical officer of DaVita Kidney Care. Dr. Giullian leads the transformation of kidney care through his commitment to providing holistic, integrated care that addresses the clinical and psychosocial needs of patients. Dr. Giullian is focused on pushing the boundaries on exemplary clinical care through innovation and expanding what is possible for patients living with kidney disease.

Jeffrey Giullian

Barbara J. Desoer, has been one of our directors since October 2015. Ms. Desoer served as the chief executive officer and a member of the board of directors of Citibank, N.A., a wholly owned subsidiary of Citigroup Inc. and a diversified global financial services company, both positions she held from April 2014 through April 2019. On April 16, 2019, Ms. Desoer joined the board of directors of Citigroup Inc. Ms. Desoer previously served as the chief operating officer of Citibank, N.A. from October 2013 to April 2014.

Prior to Citibank, Ms. Desoer spent 35 years at [Bank of America](/org/bank-of-america), a diversified global financial services company, most recently as president, [Bank of America](/org/bank-of-america) Home Loans, where she led the integration of [Countrywide](/org/countrywide-plc), the largest mortgage originator and servicer in the United States. In previous [Bank of America](/org/bank-of-america) roles, Ms. Desoer was a Global Technology & Operations executive, an international market-focused position leading teams in the United Kingdom, Asia and Latin America. She also served as president, Consumer Products. She serves on the board of visitors at the University of California at Berkeley. Ms. Desoer also has served on the board of directors of various non-profit and privately held corporations.

DaVita

Org chart

Teams

Board of Directors

CEO and Executive Team

Leadership Team

Discover similar companies